| | |
Ep-CAM expression
|
|---|
|
Variable
|
Patients
|
0
|
1+
|
2+
|
3+
|
|---|
|
Patients
| |
10
|
15
|
7
|
21
|
|
Male
|
39 (74)
|
8 (80)
|
10 (67)
|
4 (57)
|
17 (81)
|
|
Female
|
14 (26)
|
2 (20)
|
5 (33)
|
3 (43)
|
4 (19)
|
|
Primary Tumor
| | | | | |
|
pT1
|
15 (28)
|
4 (40)
|
3 (20)
|
3 (42)
|
5 (24)
|
|
pT2
|
8 (15)
|
1 (10)
|
2 (13)
|
2 (29)
|
3 (14)
|
|
pT3
|
30 (57)
|
5 (50)
|
10 (67)
|
2 (29)
|
13 (62)
|
|
Lymph node status
| | | | | |
|
pN0
|
27 (51)
|
4 (40)
|
9 (60)
|
5 (71)
|
9 (43)
|
|
pN1
|
26 (49)
|
6 (60)
|
6 (40)
|
2 (29)
|
12 (57)
|
|
Tumor grade
| | | | | |
|
G2
|
38 (72)
|
7 (70)
|
11 (73)
|
5 (71)
|
15 (71)
|
|
G3
|
15 (28)
|
3 (30)
|
4 (27)
|
2 (29)
|
6 (29)
|
- *No statistical significant correlations between Ep-CAM expression and histopathological parameters were observed.
